查看原文
其他

DIA中国年会 | 入选壁报公示:恭喜获奖学者!

DIA订阅号 2019-04-30
点击上方“DIA订阅号” 可以订阅哦!


为鼓励青年学者及医学院校学生展示工作、学习中的科研精髓及成果,第十届DIA中国年会开设有专业及学生壁报展览(5月23-25日)。


壁报征集以来,各位壁报参选者就不同专题、不同领域积极参与,反响热烈。


DIA邀请壁报评审委员会为50份提交壁报在科学性、创新性、学术性三个方面进行打分,根据分数排名筛选得出入选名单。入选壁报作者在本届年会上进行了壁报展示与5分钟讲演,现场气氛热烈,互动丰富。



以下为本次年会入选壁报:


一等奖



An alternative efficient phase 1 dose-escalation study design for early dose-range identification

Michael LEE, Atalanta GHOSH, Gary PETERS

Janssen Pharmaceutical R&D

获奖理由:This is a good thought and adaptive design on dose escalation,  it is hot and important topic. More likely to identify the correct dose range through combined the PD response, to assign subjects to does of interest, to reduce the allocation of subjects to harmful doses.

 

二等奖



A Population Pharmacokinetic Model Describing Enterohepatic Circulation of Teriflunomide Sodium in Chinese Healthy Volunteers

Xueting YAO

Peking Union Medical College Hospital

获奖理由:This poster introduces Enterohepatic Circulation of Teriflunomide Sodium in Chinese Healthy Volunteers. It’s a well-organized poster and Comprehensive study supporting current needs.


Repopulate Tet-uPA/ Rag2-/-/Il2rg-/- mouse liver with human hepatocytes for HBV infection and drug metabolism

Xijun SONG

Beijing Vitalstar Biotechnology Co.,LTD.

获奖理由:This poster is a Basic Research on inducible uPA mouse model, interesting idea in the field, The content is good enough in all aspects, but the layout can be more clear.


三等奖



Low pass whole genome sequencing of single circulating tumor cells for detection of tumor mutation burden and chromosomal instability across multiple cancer types

Yipeng WANG

Epic Sciences

获奖理由:This poster is a Basic Research. It’s a well-organized poster and audience can learn a lot from it. Hope the poster will provide more detailed and clear contents.

 

Real-time kinetic viability and apoptosis detection and screening of 3D multicellular tumor spheroids using the Image Cytometer

Mingwei SUN

Nexcelom Bioscience Instruments (Shanghai) Co. Ltd

获奖理由:This poster analyzed 3D multicellular tumor spheroids using the Image Cytometer, which could be a good reference for future.

 

Gain Visualized and Measurable Data-Driven Insights into Site Metrics

Elaine ZHAO, Yu MENG

Merck

获奖理由:This poster is Well organized proposal of a new visualized and measurable tool. The introduction of site management is comprehensive. Put more items to analysis site situation will be more helpful.


其他入选名单


Predictive modeling in Pfizer Driving Site Health

Chuda PAN

Pfizer (China) Research & Development Co, Ltd.

 

Challenge of eSource Application in Direct Data Transfer from eHR to EDC

Liheng ZHOU

Pfizer (China) Research & Development Co, Ltd.

 

Overview of Spinal Muscular Atrophy and Therapeutic Development

Lanping SHI

Roche (China) Holding Ltd.

 

An Application of Univariate Self-Controlled Case Series Method to Identify the AMI Signal among Patients Prescribed with Indomethacin Using the THIN CDM Database

Jianchang LIU, Xiaofeng ZHOU, Jingping MO

Pfizer Inc.

 

Analysis on MHRA Pharmacovigilance Inspection Findings between 2009 and 2017

Bingjie SUN, Yinhui WU

Pfizer (Shanghai) Research & Development Center

 

Interactive Progression-Free Survival Data Monitor/ Review Help Streamline Data Management and Clinical Operations Activities

Yaqing SUN, Yuan GENG

Boehringer Ingelheim (China) Investment Co., Ltd.

 

Analysis of Statistical Methodologies for Outlier Detection

Joseph ZHOU, Teresa TANG

Merck

 

Challenges and opportunities in managing global CMC submission and compliance

Yolanda FU

Pfizer (China) Research and Development Co., Ltd.

 

Overview of Aggregate Report in ICH Regions & corresponding Challenges and Resolution in China

Huijia LIU

Pfizer China R&D Center

 

Safety Reporting from Company Sponsored Marketing Programs

Jianxiong LIU

 Pfizer (China) R&D Center

 

Emerging Regulatory Operations Intelligence- Industrial Revolution 4.0

Bruce SUN

Worldwide Regulatory Operations, Pfizer

 

A Deep Learning Model for Patient Matching in Clinical Trial

Tong ZHU

 Tianjin Happy Life Tech Pharma Co., Ltd

 

Preparing in Implement Artificial Intelligence Solutions in Regulatory Operations

Sally WANG

Worldwide Regulatory Operations, Pfizer


Clinical study SAE query analysis report

Chenglin LI, Fangniu SHI, Xiaokun JIN, Wei WANG,Ping DENG, Yi LIU, Bing DU

BeiGene, CO.,LTD.

 

Artificial Intelligence in Pharmacovigilance

Ruiying LAI

Pfizer (China) Research & Development Center

 

(Biosimilars Emerging Market) Regulatory Considerations for Controlled Correspondence Related to Generics with pace of Biosimilars

Vidita DESAI 

Englewood Lab, NJ


Management of signal detection and validation methods in Pharmacovigilance from EU and US perspective

Sanjeev MIGLANI

APCER Life Sciences


Insight into new regulations in Medical Device PV arena – US and EU perspective

Mugdha CHOPRA 

APCER Life Sciences


恭喜各位入选作者!


现场图集


感谢本届年会壁报评审委员



DIA中国感谢各位青年学者与在校学生的积极参与,并邀请您持续关注DIA中国及微信平台,我们将推出更多活动,为您的职业发展、学术进步提供交流与拓展的平台。

作为中立的全球性跨学科平台

DIA始终欢迎更多的青年同行加入我们

携手推动行业的发展

关于DIA

DIA总部位于美国首都Washington DC,此外在北美、欧洲、日本、中国等设有分部。作为一家中立的国际组织,DIA 在制药和其它医疗健康领域,孜孜不倦50余年,为政府,工业和学术机构提供了形式多样的交流和学习的平台,赢得广泛认可和赞誉。 

DIA是中国医药健康研发领域必不可缺的专业分享和知识更新的伙伴


DIA微信订阅号

全新上线 !

DIA微信

订阅号

◀ 关注我

长按识别左侧二维码即可关注

我们努力为你提供有内容的内容。


    您可能也对以下帖子感兴趣

    文章有问题?点此查看未经处理的缓存